News Focus
News Focus
icon url

Ecomike

09/28/22 11:02 AM

#33149 RE: Ecomike #33147

As far as I know, there is no other drug firm / bio-tech with a phase III drug trial with a market cap anywhere near as low as the $RVVTF MC.

The Risk reward makes this a screaming a buy... today...

And the FDA asked them to prepare for and officially request a meeting to discussing how best to move forward...

The FDA needs a Covid19 winner...